Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H30O4S |
Molecular Weight | 426.568 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@]1([H])[C@@]3(CCC(=O)O3)[C@@]4(C)CC[C@@]5([H])[C@@]([H])([C@@H](CC6=CC(=O)C=C[C@]56C)SC(C)=O)[C@]24[H]
InChI
InChIKey=CPHJTSJQUQZOLJ-ISIDMKFXSA-N
InChI=1S/C25H30O4S/c1-13(26)30-19-11-14-10-15(27)4-7-23(14,2)17-5-8-24(3)22(21(17)19)16-12-18(16)25(24)9-6-20(28)29-25/h4,7,10,16-19,21-22H,5-6,8-9,11-12H2,1-3H3/t16-,17+,18+,19-,21+,22+,23+,24+,25+/m1/s1
Mespirenone (ZK 94679, 15β,16β-methylene-spironolactone) is a steroid aldosterone antagonist. In addition, it is a quite specific inhibitor of adrenocortical mineralocorticoid synthesis. In rodents mespirenone effectively prevents aldosterone-induced hypertension. It exerts natriuretic efficacy. Although it reached phase II clinical trials, it was discontinued in 1989.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists. | 1986 Nov |
|
Effect of a new mineralocorticoid antagonist mespirenone on aldosterone-induced hypertension. | 1991 Feb |
|
Potentiation of angiotensin II-induced drinking by glucocorticoids is a specific glucocorticoid type II receptor (GR)-mediated event. | 1991 Jun 28 |
|
Inhibitory effects of the novel anti-aldosterone compound mespirenone on adrenocortical steroidogenesis in vitro. | 1991 Sep |
|
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development. | 2017 Jul |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C49186
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
E91TME2I23
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
100000081167
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
SUB08788MIG
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
87952-98-5
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
Mespirenone
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
65660
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
C83938
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
CHEMBL1908314
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
5519
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
C051308
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY | |||
|
DTXSID40868989
Created by
admin on Fri Dec 15 16:11:35 GMT 2023 , Edited by admin on Fri Dec 15 16:11:35 GMT 2023
|
PRIMARY |
ACTIVE MOIETY